Evidence map›Paper›PMID 40624533›Full record

ArticleBMC palliative care2025

The variation of coverage and access to palliative care for cancer patients in eight European countries: an exploratory vignette approach.

Nathan Shuftan, Mark Dayan, Sarah Scobie, Bee Wee, Antoniya Dimova, Elka Atanasova, Liubove Murauskiene, Coralie Gandré, Zeynep Or, Gonçalo Figueiredo Augusto and 13 more

Abstract read
In one paragraph

Article in BMC palliative care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Nathan ShuftanDepartment of Healthcare Management, Technische Universität Berlin, H 80, Straße Des 17. Juni 135, Berlin, 10623, Germany. nathan.shuftan@tu-berlin.de.
Mark DayanNuffield Trust, 59 New Cavendish Street, London, W1G 7LP, UK.
Sarah ScobieNuffield Trust, 59 New Cavendish Street, London, W1G 7LP, UK.
Bee WeeNuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford, OX3 7BN, UK.
Antoniya DimovaMedical University of Varna, 55 Marin Drinov Str, Varna, 9002, Bulgaria.
Elka AtanasovaMedical University of Varna, 55 Marin Drinov Str, Varna, 9002, Bulgaria.
Liubove MurauskieneDepartment of Public Health, Faculty of Medicine, Institute of Health Sciences, Vilnius University, M. K. Čiurlionio G. 21/27, Vilnius, 03101, Lithuania.
Coralie GandréInstitute for Research and Information in Health Economics (IRDES), 21-23, Rue Des Ardennes, Paris, 75019, France.
Zeynep OrInstitute for Research and Information in Health Economics (IRDES), 21-23, Rue Des Ardennes, Paris, 75019, France.
Gonçalo Figueiredo AugustoNOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, NOVA University Lisbon, Rua da Junqueira, 100, Lisbon, 1349-008, Portugal.
Triin HabichtWHO Barcelona Office for Health Systems Financing, Sant Pau Art Nouveau Site (La Mercè Pavilion), Sant Antoni Maria Claret, 167, Barcelona, 08025, Spain.
Kristina KöhlerWHO Country Office, Paldiski Road 81, Tallinn, 10617, Estonia.
Kristiina KahurHC Management Consulting Ltd, Tallinn, Estonia.
Bertil AxelssonDepartment of Radiation Sciences, University Hospital of Umeå, Daniel Naezéns Väg, Umeå, 907 37, Sweden.
Madelon KronemanNivel, Netherlands Institute for Health Services Research, Otterstraat 118, Utrecht, CR, 3513, The Netherlands.
Judith de JongNivel, Netherlands Institute for Health Services Research, Otterstraat 118, Utrecht, CR, 3513, The Netherlands.
Anke de VeerNivel, Netherlands Institute for Health Services Research, Otterstraat 118, Utrecht, CR, 3513, The Netherlands.
Wanda BemelmansNivel, Netherlands Institute for Health Services Research, Otterstraat 118, Utrecht, CR, 3513, The Netherlands.
Chantal PereiraNetherlands Comprehensive Care Organisation (IKNL), Godebaldkwartier 419, Utrecht, DT, 3511, The Netherlands.
Ajay AggarwalKing's College London, Guy's Campus, Great Maze Pond, London, SE1 1UL, UK.
Joanna DaviesGeorge's University NHS Foundation Trust, Blackshaw Road, London, SW17 0QT, UK.
Ewout van GinnekenEuropean Observatory On Health Systems and Policies, WHO European Centre for Health Policy, Eurostation (Office 07C020), Place Victor Horta/Victor Hortaplein, 40/10, 1060, Brussels, Belgium.
Dimitra PanteliEuropean Observatory On Health Systems and Policies, WHO European Centre for Health Policy, Eurostation (Office 07C020), Place Victor Horta/Victor Hortaplein, 40/10, 1060, Brussels, Belgium.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundPalliative care aims to maintain quality of life and offer treatment and person-centred care options for people with serious end-stage illnesses and their families. The purpose of this exploratory study was to compare the statutory coverage and access to palliative care for adult services for people with cancer in 8 European countries using a vignette approach.

methodsWe used a patient vignette to examine coverage and access to palliative care services across Europe. The palliative care vignette describes a pathway based on guidance for best practices of palliative care patients with incurable cancer. The surveys accompanying the vignette were completed by health services researchers knowledgeable on palliative care, practitioners, government officials, or teams consisting of a health systems expert working together with practitioners.

resultsCompleted vignettes were received from 8 countries: Bulgaria, Estonia, France, Lithuania, the Netherlands, Portugal, Sweden and England. Services provided for palliative care envisioned in the vignette's pathway are, generally, covered by the statutory health systems. However, in some countries cost sharing exists for hospital stays, certain medicines and medical aids. Furthermore, coverage of social and financial assessments, home equipment and financial advice varied in nearly every country. Travel times to and availability of palliative care specialists were identified as challenges across nearly all countries. Organizational barriers, societal stigmas and knowledge gaps about what palliative care entails were also found to be areas in need of improvement.

conclusionsThe comparative research presented provides further insight how countries organise palliative care, how services are offered and what levels of access exist around Europe. Our study showed differences in the scope of coverage of and access to the care options in the vignette. While responses showed countries have basic levels of coverage and access to services provided, there were variations, such as availability of specialists or the extent travel and waiting times influence care delivery. Settings where patients receive services also varied. As the need for palliative care grows in the future, health ministries and insurers should be increasingly concerned with how to guarantee coverage of and access to this care, as well as aware of best practices among countries facing similar challenges.

Indexed as

Health Services AccessibilityNeoplasmsPalliative CareAdultBulgariaEnglandEuropeFemaleHumansLithuaniaMaleMiddle AgedNetherlandsPortugalSurveys and QuestionnairesAccessBenefit packageCost-sharingCoverageFinancial protectionPalliative care

Identifiers

PMID40624533
PMCPMC12235821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.